260 related articles for article (PubMed ID: 38356054)
1. Potential Role of Nrf2, HER2, and ALDH in Cancer Stem Cells: A Narrative Review.
Fakhrioliaei A; Tanhaei S; Pakmehr S; Noori Shakir M; Qasim MT; Hariri M; Nouhi Kararoudi A; Valilo M
J Membr Biol; 2024 Apr; 257(1-2):3-16. PubMed ID: 38356054
[TBL] [Abstract][Full Text] [Related]
2. Aldehyde dehydrogenases and cancer stem cells.
Xu X; Chai S; Wang P; Zhang C; Yang Y; Yang Y; Wang K
Cancer Lett; 2015 Dec; 369(1):50-7. PubMed ID: 26319899
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology underlying the robustness of cancer stem cells.
Yoshida GJ; Saya H
Regen Ther; 2021 Jun; 17():38-50. PubMed ID: 33869685
[TBL] [Abstract][Full Text] [Related]
4. Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance.
Payandeh Z; Pirpour Tazehkand A; Barati G; Pouremamali F; Kahroba H; Baradaran B; Samadi N
Biochimie; 2020 Dec; 179():32-45. PubMed ID: 32946993
[TBL] [Abstract][Full Text] [Related]
5. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
Kim D; Choi BH; Ryoo IG; Kwak MK
Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
[TBL] [Abstract][Full Text] [Related]
6. Targeting Aldehyde Dehydrogenases to Eliminate Cancer Stem Cells in Gynecologic Malignancies.
Muralikrishnan V; Hurley TD; Nephew KP
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32295073
[TBL] [Abstract][Full Text] [Related]
7. Targeting cancer stem cells by using the nanoparticles.
Hong IS; Jang GB; Lee HY; Nam JS
Int J Nanomedicine; 2015; 10(Spec Iss):251-60. PubMed ID: 26425092
[TBL] [Abstract][Full Text] [Related]
8. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy.
Cui Y; Zhao M; Yang Y; Xu R; Tong L; Liang J; Zhang X; Sun Y; Fan Y
Acta Biomater; 2022 Oct; 152():380-392. PubMed ID: 36028199
[TBL] [Abstract][Full Text] [Related]
9. Nuclear Factor Erythroid-Derived 2-Like 2-Induced Reductive Stress Favors Self-Renewal of Breast Cancer Stem-Like Cells
Kim DH; Jang JH; Kwon OS; Cha HJ; Youn HJ; Chun KS; Surh YJ
Antioxid Redox Signal; 2020 Jun; 32(18):1313-1329. PubMed ID: 31672029
[No Abstract] [Full Text] [Related]
10. Transforming growth factor-β1-induced epithelial-mesenchymal transition generates ALDH-positive cells with stem cell properties in cholangiocarcinoma.
Shuang ZY; Wu WC; Xu J; Lin G; Liu YC; Lao XM; Zheng L; Li S
Cancer Lett; 2014 Nov; 354(2):320-8. PubMed ID: 25194504
[TBL] [Abstract][Full Text] [Related]
11. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment.
Kim JY; Lee HY; Park KK; Choi YK; Nam JS; Hong IS
Oncotarget; 2016 Apr; 7(15):20395-409. PubMed ID: 26967248
[TBL] [Abstract][Full Text] [Related]
12. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.
Kim IG; Kim SY; Choi SI; Lee JH; Kim KC; Cho EW
Oncogene; 2014 Jul; 33(30):3908-17. PubMed ID: 24013232
[TBL] [Abstract][Full Text] [Related]
13. Novel therapeutic strategies for targeting liver cancer stem cells.
Oishi N; Wang XW
Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
[TBL] [Abstract][Full Text] [Related]
14. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.
Aramini B; Masciale V; Grisendi G; Bertolini F; Maur M; Guaitoli G; Chrystel I; Morandi U; Stella F; Dominici M; Haider KH
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205721
[TBL] [Abstract][Full Text] [Related]
15. Conflicting metabolic alterations in cancer stem cells and regulation by the stromal niche.
Yasuda T; Ishimoto T; Baba H
Regen Ther; 2021 Jun; 17():8-12. PubMed ID: 33598509
[TBL] [Abstract][Full Text] [Related]
16. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
17. A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells.
Wu Y; Tran T; Dwabe S; Sarkissyan M; Kim J; Nava M; Clayton S; Pietras R; Farias-Eisner R; Vadgama JV
Breast Cancer Res Treat; 2017 Jun; 163(3):449-460. PubMed ID: 28337662
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.
Mizuno T; Suzuki N; Makino H; Furui T; Morii E; Aoki H; Kunisada T; Yano M; Kuji S; Hirashima Y; Arakawa A; Nishio S; Ushijima K; Ito K; Itani Y; Morishige K
Gynecol Oncol; 2015 May; 137(2):299-305. PubMed ID: 25541259
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition.
Warrier S; Bhuvanalakshmi G; Arfuso F; Rajan G; Millward M; Dharmarajan A
Cancer Gene Ther; 2014 Sep; 21(9):381-8. PubMed ID: 25104726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]